Q32 Bio Inc (QTTB) Stock Analysis
Verdict: WATCH (do not buy)
Phase II pipeline potential is balanced by a 17-month cash runway and executive insider selling, keeping near-term value bound.
Investment score: 52/100
Analysis as of
Is Q32 Bio Inc stock worth reviewing? AI model thesis
The AI model sees Q32 Bio as a Hold. Near-term pipeline milestones offer speculative upside, but limited cash runway and insider selling create notable drag.
7-factor investment score
- Valuation: 50/100 (weight 20%)
- Financial Health: 55/100 (weight 15%)
- Technical Momentum: 40/100 (weight 15%)
- Earnings Quality: 65/100 (weight 15%)
- Insider Sentiment: 35/100 (weight 10%)
- Analyst Consensus: 75/100 (weight 10%)
- Risk-Adjusted Return: 45/100 (weight 15%)
Q32 Bio Inc opportunities and risks
What speaks for QTTB
- Bempikibart Phase II Readouts in Alopecia Areata
What speaks against QTTB
- Cash Burn and Dilution Risk Within 17 Months
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| QTTB | 4.0x | 6.1x | 6.6x | 99.8% | 62.9% | -6.0% |
| OCGN | n/a | 77.4x | n/a | 100.0% | -1786.3% | -17.3% |
| IPSC | n/a | 0.0x | n/a | 0.0% | 0.0% | -53.7% |
| CMPX | n/a | 0.0x | n/a | 0.0% | 0.0% | -16.1% |
| SION | n/a | 0.0x | n/a | 0.0% | 0.0% | -28.5% |
| RCEL | n/a | 3.5x | n/a | 81.6% | -57.0% | -8.8% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -17.3% |
Frequently asked questions about Q32 Bio Inc (QTTB)
Is QTTB stock a good investment?
The cached TradeMates AI model rates Q32 Bio Inc as WATCH (do not buy) with an investment score of 52/100. The AI model sees Q32 Bio as a Hold. Near-term pipeline milestones offer speculative upside, but limited cash runway and insider selling create notable drag. This is algorithmic model output, not personal investment advice.
Is QTTB stock a buy?
The TradeMates model verdict for QTTB is WATCH (do not buy) with an investment score of 52/100. Treat this as a model signal to review, not a personal buy recommendation.